Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127228) titled 'Effectiveness and Safety of Doxazosin Mesylate in the Treatment of Pelvic Lipomatosis: A Prospective Cohort Study' on June 26.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University First Hospital
Condition:
Pelvic Lipomatosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Doxazosin Mesylate treatment group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=330058
Published by HT Digital Content Services with permission from Health Daily Digest....